又一上市大医企，原实控人、财务总监双双判刑...

Core Viewpoint - Yunnan Biovalley Pharmaceutical Co., Ltd. (referred to as "Biovalley") announced that the Yunnan Provincial High People's Court has made a final ruling regarding the original actual controller Lin Yanhua and former financial director He Yuan, sentencing Lin to three years in prison and a fine of 5 million yuan, while He was sentenced to one and a half years in prison and a fine of 2 million yuan for the crime of breaching trust and harming the interests of the listed company [1][16][30] Group 1: Legal Proceedings and Sentencing - Lin Yanhua, the original actual controller and chairman of Biovalley, and He Yuan, the former financial director, were found guilty of breaching trust and harming the interests of the company [7][21] - The court ruled that Lin Yanhua was sentenced to three years in prison and fined 5 million yuan, while He Yuan received a sentence of one and a half years and a fine of 2 million yuan [7][21] - The court also ordered the return of 62 million yuan that was frozen and misappropriated funds to be returned to Biovalley [7][21] Group 2: Financial Misconduct Details - From August 27, 2021, to March 11, 2022, Lin Yanhua arranged for He Yuan to violate financial management regulations, misappropriating company funds for non-operational purposes [6][19] - The misappropriated funds were transferred to Yinfengtai Fund Management Co., Ltd. and Guoshen Financing Leasing (Yunnan) Co., Ltd., and were used to support the daily operations and debt repayment of the company controlled by Lin Yanhua, Shenzhen Jinshajiang Investment Co., Ltd. [6][19] - The total amount of misappropriated funds was reported to be 62 million yuan, which has been frozen by law enforcement [6][19] Group 3: Company Impact and Response - The criminal ruling is not expected to have a significant impact on the company's production and operations [9][23] - Upon receiving the frozen 62 million yuan, the company will conduct appropriate accounting treatment as per accounting standards [9][23] - Biovalley has engaged a law firm to pursue legal action against related parties to recover the principal and compensate for the losses incurred due to the fund misappropriation [10][23]